Japan Plans Testing Bird Flu Vaccine On Medical Workers
This article was originally published in PharmAsia News
Japan's health ministry says it plans to test avian influenza vaccines on 6,000 medical workers and quarantine officers to determine the effectiveness of the drugs. The plan, which needs approval of a panel of experts, is to begin by the end of next March. If the initial vaccination of the 6,000 workers is successful, the ministry says, it would consider using the rest of its stockpile capable of vaccinating 10 million people. (Click here for more
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.